| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIFBP NDE1 MYO7A MYO10 DBN1 ADCY8 TAOK2 PRUNE1 PTPN4 DST CLTC AFDN TTLL1 PLEC DMD NOS3 CLASP1 CORO1B KLC4 NKD2 KIRREL1 MACF1 CDK5RAP2 MYH15 MYO16 EPB41 | 5.32e-05 | 1099 | 203 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | arginine binding | 8.31e-05 | 9 | 203 | 3 | GO:0034618 | |
| GeneOntologyMolecularFunction | cadherin binding | DBN1 EPS15L1 AFDN PLEC NOS3 GOLGA3 RARS1 CORO1B IDH1 MACF1 CDH3 PCMT1 | 1.92e-04 | 339 | 203 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | dystroglycan binding | 2.13e-04 | 12 | 203 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase activity | 3.06e-04 | 3 | 203 | 2 | GO:0004517 | |
| GeneOntologyMolecularFunction | actin binding | MYO7A MYO10 DBN1 ADCY8 DST AFDN PLEC DMD NOS3 CORO1B MACF1 MYH15 MYO16 EPB41 | 4.09e-04 | 479 | 203 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 5.43e-04 | 227 | 203 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.97e-04 | 230 | 203 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 6.09e-04 | 4 | 203 | 2 | GO:0034617 | |
| GeneOntologyMolecularFunction | zinc ion binding | UBR1 NAPEPLD ZMYM2 ZCCHC14 DHH ZNF638 KDM2B DMD NOS1 MPI TRIM51 PRICKLE1 POLA1 NR4A2 TRIM64 DPP3 TRIM64B POLR3B RNPEP TOP3A | 7.85e-04 | 891 | 203 | 20 | GO:0008270 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SART3 KIFBP RELN TRIO MYO7A MYO10 TSC2 DBN1 TAOK2 FAT1 DST HECW2 AFDN PLEC DMD PLXNA2 ARAP1 ARHGEF28 NRDC SZT2 PRICKLE1 FAT3 LRATD1 NR4A2 SHOX2 CORO1B SIPA1 IDUA ARHGEF25 DICER1 ATL1 SLIT1 MACF1 ROBO2 EIF2AK4 CDH3 MYO16 EPB41 | 9.93e-11 | 1194 | 202 | 38 | GO:0000902 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | KIFBP RELN TRIO TSC2 DBN1 TAOK2 DST HECW2 AFDN DMD PLXNA2 ARHGEF28 NRDC SZT2 PRICKLE1 NR4A2 SHOX2 CORO1B ARHGEF25 DICER1 ATL1 SLIT1 MACF1 ROBO2 EIF2AK4 MYO16 | 1.33e-07 | 819 | 202 | 26 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | KIFBP RELN TRIO TSC2 DBN1 TAOK2 DST HECW2 AFDN DMD PLXNA2 ARHGEF28 NRDC SZT2 PRICKLE1 NR4A2 SHOX2 CORO1B ARHGEF25 DICER1 ATL1 SLIT1 MACF1 ROBO2 EIF2AK4 MYO16 | 1.57e-07 | 826 | 202 | 26 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | KIFBP RELN TRIO TSC2 DBN1 TAOK2 DST HECW2 AFDN DMD PLXNA2 ARHGEF28 NRDC SZT2 PRICKLE1 NR4A2 SHOX2 ARHGEF25 DICER1 ATL1 SLIT1 MACF1 ROBO2 EIF2AK4 MYO16 | 3.33e-07 | 802 | 202 | 25 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron projection development | KIFBP RELN TRIO MYO7A TSC2 DBN1 ADCY6 TAOK2 FBXO38 BMP4 DST HECW2 AFDN DMD PLXNA2 ARHGEF28 NRDC SZT2 PRICKLE1 FAT3 ROR1 NR4A2 SHOX2 ARHGEF25 DICER1 ATL1 CBFA2T2 CSPG4 SLIT1 MACF1 ROBO2 EIF2AK4 MYO16 | 3.39e-07 | 1285 | 202 | 33 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | KIFBP RELN TRIO MYO7A TSC2 DBN1 ADCY6 TAOK2 FBXO38 BMP4 DST HECW2 AFDN DMD PLXNA2 ARHGEF28 NRDC SZT2 PRICKLE1 HCN1 FAT3 ROR1 NR4A2 SHOX2 ARHGEF25 LGI4 DICER1 ATL1 CBFA2T2 CSPG4 SLIT1 MACF1 ROBO2 EIF2AK4 MYO16 | 7.50e-07 | 1463 | 202 | 35 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | KIFBP RELN TRIO MYO7A TSC2 DBN1 TAOK2 DST HECW2 AFDN PLXNA2 ARHGEF28 NRDC SZT2 PRICKLE1 FAT3 NR4A2 SHOX2 ARHGEF25 ATL1 SLIT1 MACF1 ROBO2 | 1.29e-06 | 748 | 202 | 23 | GO:0048667 |
| GeneOntologyBiologicalProcess | axonogenesis | KIFBP RELN TRIO TSC2 DBN1 TAOK2 DST PLXNA2 ARHGEF28 NRDC SZT2 PRICKLE1 NR4A2 SHOX2 ARHGEF25 ATL1 SLIT1 MACF1 ROBO2 | 3.26e-06 | 566 | 202 | 19 | GO:0007409 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 5.88e-06 | 99 | 202 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 6.34e-06 | 100 | 202 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | RELN TSC2 DBN1 ADCY6 FBXO38 BMP4 HECW2 AFDN DMD PLXNA2 NRDC FAT3 ROR1 SHOX2 CBFA2T2 CSPG4 SLIT1 MACF1 ROBO2 | 9.94e-06 | 612 | 202 | 19 | GO:0010975 |
| GeneOntologyBiologicalProcess | axon development | KIFBP RELN TRIO TSC2 DBN1 TAOK2 DST PLXNA2 ARHGEF28 NRDC SZT2 PRICKLE1 NR4A2 SHOX2 ARHGEF25 ATL1 SLIT1 MACF1 ROBO2 | 1.93e-05 | 642 | 202 | 19 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | RELN MYO10 TSC2 DBN1 ADCY6 FBXO38 BMP4 HECW2 AFDN DMD PLXNA2 ARAP1 NRDC FAT3 ROR1 SHOX2 CORO1B CBFA2T2 CSPG4 SLIT1 MACF1 ROBO2 | 3.06e-05 | 846 | 202 | 22 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | RELN TSC2 DBN1 FBXO38 BMP4 AFDN DMD PLXNA2 ARAP1 NRDC ROR1 SHOX2 CORO1B CBFA2T2 MACF1 ROBO2 | 3.09e-05 | 494 | 202 | 16 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | RELN MYO10 TSC2 DBN1 ADCY6 FBXO38 BMP4 HECW2 AFDN DMD PLXNA2 ARAP1 NRDC FAT3 ROR1 SHOX2 CORO1B CBFA2T2 CSPG4 SLIT1 MACF1 ROBO2 | 4.12e-05 | 863 | 202 | 22 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 9.03e-05 | 185 | 202 | 9 | GO:0099175 | |
| GeneOntologyBiologicalProcess | Schwann cell development | 9.42e-05 | 47 | 202 | 5 | GO:0014044 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 1.40e-04 | 115 | 202 | 7 | GO:0150115 | |
| GeneOntologyBiologicalProcess | cell junction assembly | RELN CARMIL3 ACVRL1 TAOK2 DST AFDN PLEC BSN PDCD6IP CLASP1 PRICKLE1 UBE3B SLIT1 MACF1 ROBO2 CDH3 | 1.61e-04 | 569 | 202 | 16 | GO:0034329 |
| GeneOntologyBiologicalProcess | Schwann cell differentiation | 2.00e-04 | 55 | 202 | 5 | GO:0014037 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | NDE1 TSC2 FAT1 DST PDCD6IP CLASP1 PRICKLE1 SIPA1 MACF1 CDK5RAP2 | 2.33e-04 | 257 | 202 | 10 | GO:0007163 |
| GeneOntologyBiologicalProcess | peripheral nervous system axon ensheathment | 2.92e-04 | 33 | 202 | 4 | GO:0032292 | |
| GeneOntologyBiologicalProcess | myelination in peripheral nervous system | 2.92e-04 | 33 | 202 | 4 | GO:0022011 | |
| GeneOntologyCellularComponent | supramolecular fiber | EPPK1 NDE1 DBN1 EFHB RYR1 PARP4 TEKT2 DST KRT77 CLTC TTLL1 PLEC DMD NOS1 DYNC1H1 COL6A3 KRT9 CLASP1 KRT19 DYNC2H1 MYOM3 CORO1B KLC4 ARHGEF25 MACF1 CDK5RAP2 MYH15 CSPP1 | 1.09e-05 | 1179 | 203 | 28 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | EPPK1 NDE1 DBN1 EFHB RYR1 PARP4 TEKT2 DST KRT77 CLTC TTLL1 PLEC DMD NOS1 DYNC1H1 COL6A3 KRT9 CLASP1 KRT19 DYNC2H1 MYOM3 CORO1B KLC4 ARHGEF25 MACF1 CDK5RAP2 MYH15 CSPP1 | 1.24e-05 | 1187 | 203 | 28 | GO:0099081 |
| GeneOntologyCellularComponent | sarcolemma | 1.74e-05 | 190 | 203 | 10 | GO:0042383 | |
| GeneOntologyCellularComponent | basal part of cell | EPPK1 NAIP ADCY8 DST OTOF PLEC CLASP1 HCN1 TFRC NKD2 SLC39A14 EPB41 CDH16 PCMT1 | 2.10e-05 | 378 | 203 | 14 | GO:0045178 |
| GeneOntologyCellularComponent | postsynaptic density | SIGMAR1 TSC2 DBN1 ADCY8 DST AFDN DMD BSN NOS1 PRICKLE1 DICER1 MACF1 ROBO2 INSYN2B TANC1 | 3.70e-05 | 451 | 203 | 15 | GO:0014069 |
| GeneOntologyCellularComponent | basal plasma membrane | EPPK1 NAIP ADCY8 DST OTOF PLEC HCN1 TFRC NKD2 SLC39A14 EPB41 CDH16 PCMT1 | 4.54e-05 | 354 | 203 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | postsynapse | NAPEPLD TRIO SIGMAR1 CARMIL3 TSC2 DBN1 ADCY8 CHRNB3 TAOK2 DST CLTC AFDN DMD BSN NOS1 PRICKLE1 HCN1 UBE3B DICER1 TFRC MACF1 ROBO2 INSYN2B TANC1 | 5.50e-05 | 1018 | 203 | 24 | GO:0098794 |
| GeneOntologyCellularComponent | neuron to neuron synapse | NAPEPLD SIGMAR1 TSC2 DBN1 ADCY8 DST AFDN DMD BSN NOS1 PRICKLE1 DICER1 MACF1 ROBO2 INSYN2B TANC1 | 5.52e-05 | 523 | 203 | 16 | GO:0098984 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EPPK1 NDE1 DBN1 EFHB PARP4 TEKT2 DST KRT77 CLTC TTLL1 PLEC DMD DYNC1H1 KRT9 CLASP1 KRT19 DYNC2H1 CORO1B KLC4 MACF1 CDK5RAP2 CSPP1 | 6.67e-05 | 899 | 203 | 22 | GO:0099513 |
| GeneOntologyCellularComponent | asymmetric synapse | SIGMAR1 TSC2 DBN1 ADCY8 DST AFDN DMD BSN NOS1 PRICKLE1 DICER1 MACF1 ROBO2 INSYN2B TANC1 | 6.97e-05 | 477 | 203 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | cell cortex | MYO7A MYO10 DBN1 RYR1 DST AKT2 BSN DYNC1H1 CLASP1 KRT19 MACF1 EXOC1 EPB41 | 7.31e-05 | 371 | 203 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | postsynaptic specialization | SIGMAR1 TSC2 DBN1 ADCY8 DST AFDN DMD BSN NOS1 PRICKLE1 DICER1 MACF1 ROBO2 INSYN2B TANC1 | 1.25e-04 | 503 | 203 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | hemidesmosome | 1.41e-04 | 11 | 203 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | myosin complex | 2.69e-04 | 59 | 203 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | EPPK1 NAIP ADCY8 OTOF HCN1 TFRC NKD2 SLC39A14 EPB41 CDH16 PCMT1 | 3.09e-04 | 320 | 203 | 11 | GO:0016323 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | TSC2 DBN1 RYR1 FAT1 DST PLEC DMD NOS1 RGPD2 KRT9 PSMF1 CORO1B SIPA1 DICER1 TFRC PACS1 KIRREL1 CDK5RAP2 EXOC1 MYO16 CDK4 | 3.12e-04 | 934 | 203 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO7A MYO10 DBN1 ADCY8 TAOK2 DST PDCD6IP KRT19 ROR1 CORO1B MACF1 MYH15 CGNL1 MYO16 EPB41 | 5.30e-04 | 576 | 203 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | anchoring junction | EPPK1 SIGMAR1 DBN1 PRUNE1 FAT1 FAT2 DST CLTC AFDN PLEC DMD PDCD6IP CLASP1 CORO1B PANX2 TSPAN33 CSPG4 KIRREL1 CGNL1 CDH3 CDK4 | 5.56e-04 | 976 | 203 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | ASAP complex | 5.56e-04 | 4 | 203 | 2 | GO:0061574 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 5.94e-04 | 147 | 203 | 7 | GO:0030665 | |
| GeneOntologyCellularComponent | microtubule | NDE1 EFHB PARP4 TEKT2 DST CLTC TTLL1 DYNC1H1 CLASP1 DYNC2H1 KLC4 MACF1 CDK5RAP2 CSPP1 | 7.46e-04 | 533 | 203 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 8.71e-04 | 114 | 203 | 6 | GO:0005798 | |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network membrane | 9.21e-04 | 5 | 203 | 2 | GO:0098826 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.10e-03 | 80 | 203 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | axon | RELN SIGMAR1 TSC2 DBN1 ADCY8 TAOK2 DST AFDN PLEC DMD BSN NOS1 DYNC1H1 HCN1 ROR1 DICER1 ATL1 ROBO2 TANC1 | 1.14e-03 | 891 | 203 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle membrane | 1.21e-03 | 22 | 203 | 3 | GO:0012510 | |
| GeneOntologyCellularComponent | costamere | 1.21e-03 | 22 | 203 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 1.37e-03 | 6 | 203 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | myofibril | 1.45e-03 | 273 | 203 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | intermediate filament | 1.74e-03 | 227 | 203 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.18e-03 | 290 | 203 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | microtubule plus-end | 2.47e-03 | 28 | 203 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.58e-03 | 141 | 203 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | glutamatergic synapse | TRIO CARMIL3 TSC2 DBN1 ADCY8 TAOK2 CLTC BSN NOS1 PRICKLE1 HCN1 UBE3B CORO1B DICER1 SACM1L ROBO2 TANC1 | 2.66e-03 | 817 | 203 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 2.92e-03 | 61 | 203 | 4 | GO:0030660 | |
| GeneOntologyCellularComponent | sarcomere | 3.08e-03 | 249 | 203 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | clathrin complex | 3.23e-03 | 9 | 203 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | cell projection membrane | NAPEPLD MYO10 ADCY6 AKT2 DMD HCN1 CSPG4 KIRREL1 MACF1 ROBO2 PCMT1 | 3.38e-03 | 431 | 203 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | Z disc | 3.62e-03 | 151 | 203 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | ribbon synapse | 3.64e-03 | 32 | 203 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | cell leading edge | MYO10 CARMIL3 DBN1 FAT1 DST AKT2 DMD HCN1 CORO1B CSPG4 MACF1 ROBO2 | 3.68e-03 | 500 | 203 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 4.11e-03 | 67 | 203 | 4 | GO:0098686 | |
| GeneOntologyCellularComponent | cell-substrate junction | EPPK1 PRUNE1 FAT1 DST CLTC PLEC DMD PDCD6IP CLASP1 CORO1B CSPG4 | 4.16e-03 | 443 | 203 | 11 | GO:0030055 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 4.29e-03 | 263 | 203 | 8 | GO:0045111 | |
| Domain | - | 1.96e-07 | 6 | 202 | 4 | 3.90.1290.10 | |
| Domain | Plectin | 4.53e-07 | 7 | 202 | 4 | PF00681 | |
| Domain | Plectin_repeat | 4.53e-07 | 7 | 202 | 4 | IPR001101 | |
| Domain | PLEC | 4.53e-07 | 7 | 202 | 4 | SM00250 | |
| Domain | Spectrin_repeat | 5.74e-07 | 29 | 202 | 6 | IPR002017 | |
| Domain | SPEC | 1.07e-06 | 32 | 202 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.07e-06 | 32 | 202 | 6 | IPR018159 | |
| Domain | LAM_G_DOMAIN | 5.29e-05 | 38 | 202 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 6.81e-05 | 40 | 202 | 5 | PF02210 | |
| Domain | Spectrin | 1.00e-04 | 23 | 202 | 4 | PF00435 | |
| Domain | ACTININ_2 | 1.00e-04 | 23 | 202 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.00e-04 | 23 | 202 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.00e-04 | 23 | 202 | 4 | IPR001589 | |
| Domain | LamG | 1.09e-04 | 44 | 202 | 5 | SM00282 | |
| Domain | Clathrin_H-chain_propeller_rpt | 1.16e-04 | 2 | 202 | 2 | IPR022365 | |
| Domain | Clathrin-link | 1.16e-04 | 2 | 202 | 2 | PF09268 | |
| Domain | - | 1.16e-04 | 2 | 202 | 2 | 2.130.10.110 | |
| Domain | Clathrin_heavy_chain | 1.16e-04 | 2 | 202 | 2 | IPR016341 | |
| Domain | Clathrin_H-chain_propeller_N | 1.16e-04 | 2 | 202 | 2 | IPR001473 | |
| Domain | Clathrin_H-chain_link/propller | 1.16e-04 | 2 | 202 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 1.16e-04 | 2 | 202 | 2 | PF01394 | |
| Domain | Clathrin_H-chain_linker_core | 1.16e-04 | 2 | 202 | 2 | IPR015348 | |
| Domain | TPR-like_helical_dom | 2.32e-04 | 233 | 202 | 10 | IPR011990 | |
| Domain | Clathrin_H-chain_linker | 3.47e-04 | 3 | 202 | 2 | IPR012331 | |
| Domain | NO_synthase | 3.47e-04 | 3 | 202 | 2 | PF02898 | |
| Domain | NOS_euk | 3.47e-04 | 3 | 202 | 2 | IPR012144 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 3.90.340.10 | |
| Domain | NOS_N | 3.47e-04 | 3 | 202 | 2 | IPR004030 | |
| Domain | NOS | 3.47e-04 | 3 | 202 | 2 | PS60001 | |
| Domain | CLH | 3.47e-04 | 3 | 202 | 2 | SM00299 | |
| Domain | Laminin_G | 4.05e-04 | 58 | 202 | 5 | IPR001791 | |
| Domain | - | 4.33e-04 | 207 | 202 | 9 | 1.25.40.10 | |
| Domain | IQ | 5.19e-04 | 93 | 202 | 6 | PS50096 | |
| Domain | - | 5.69e-04 | 261 | 202 | 10 | 1.10.238.10 | |
| Domain | ConA-like_dom | 6.50e-04 | 219 | 202 | 9 | IPR013320 | |
| Domain | DUF1693 | 6.88e-04 | 4 | 202 | 2 | IPR012937 | |
| Domain | DUF1693 | 6.88e-04 | 4 | 202 | 2 | SM01153 | |
| Domain | NTP_transf_7 | 6.88e-04 | 4 | 202 | 2 | PF07984 | |
| Domain | Myosin_head_motor_dom | 7.35e-04 | 38 | 202 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.35e-04 | 38 | 202 | 4 | PS51456 | |
| Domain | Myosin_head | 7.35e-04 | 38 | 202 | 4 | PF00063 | |
| Domain | MYSc | 7.35e-04 | 38 | 202 | 4 | SM00242 | |
| Domain | RA_dom | 8.95e-04 | 40 | 202 | 4 | IPR000159 | |
| Domain | EF-hand-dom_pair | 1.17e-03 | 287 | 202 | 10 | IPR011992 | |
| Domain | FERM_M | 1.52e-03 | 46 | 202 | 4 | PF00373 | |
| Domain | CA | 1.57e-03 | 115 | 202 | 6 | SM00112 | |
| Domain | Adcy_conserved_dom | 1.70e-03 | 6 | 202 | 2 | IPR009398 | |
| Domain | FAD_binding_1 | 1.70e-03 | 6 | 202 | 2 | PF00667 | |
| Domain | GAR | 1.70e-03 | 6 | 202 | 2 | PS51460 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 1.20.990.10 | |
| Domain | DUF1053 | 1.70e-03 | 6 | 202 | 2 | PF06327 | |
| Domain | GAS2 | 1.70e-03 | 6 | 202 | 2 | PF02187 | |
| Domain | FAD-binding_1 | 1.70e-03 | 6 | 202 | 2 | IPR003097 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 3.30.920.20 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 1.70e-03 | 6 | 202 | 2 | IPR023173 | |
| Domain | GAS_dom | 1.70e-03 | 6 | 202 | 2 | IPR003108 | |
| Domain | GAS2 | 1.70e-03 | 6 | 202 | 2 | SM00243 | |
| Domain | EF_HAND_1 | 1.74e-03 | 204 | 202 | 8 | PS00018 | |
| Domain | Cadherin | 1.80e-03 | 118 | 202 | 6 | IPR002126 | |
| Domain | IQ | 1.85e-03 | 81 | 202 | 5 | SM00015 | |
| Domain | - | 1.92e-03 | 49 | 202 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 1.92e-03 | 49 | 202 | 4 | IPR019748 | |
| Domain | FERM_domain | 1.92e-03 | 49 | 202 | 4 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.07e-03 | 50 | 202 | 4 | IPR014352 | |
| Domain | FERM_1 | 2.07e-03 | 50 | 202 | 4 | PS00660 | |
| Domain | FERM_2 | 2.07e-03 | 50 | 202 | 4 | PS00661 | |
| Domain | FERM_3 | 2.07e-03 | 50 | 202 | 4 | PS50057 | |
| Domain | Band_41_domain | 2.07e-03 | 50 | 202 | 4 | IPR019749 | |
| Domain | B41 | 2.07e-03 | 50 | 202 | 4 | SM00295 | |
| Domain | Clathrin | 2.36e-03 | 7 | 202 | 2 | PF00637 | |
| Domain | CHCR | 2.36e-03 | 7 | 202 | 2 | PS50236 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TMEM120B EPPK1 CLTCL1 TRIO MYO7A MYO10 TSC2 RYR1 TAOK2 ZCCHC14 BMP4 EPS15L1 URB1 FAT1 DST AKT2 PLEC DYNC1H1 ARAP1 NRF1 SZT2 NLRX1 UBE3B MYOM3 CORO1B IDUA PLCD3 CSPG4 TANC1 TOP3A | 3.51e-12 | 1105 | 205 | 30 | 35748872 |
| Pubmed | SART3 KIFBP BRPF3 ERMP1 TAOK2 TRANK1 DST HECW2 DHCR24 KDM2B BSN CARNS1 ARAP1 SATB2 PDCD6IP SZT2 DICER1 CDK5RAP2 ROBO2 EIF2AK4 HPS5 | 8.10e-12 | 529 | 205 | 21 | 14621295 | |
| Pubmed | SART3 TRIO MYO7A FKBP9 DBN1 CCDC177 EPS15L1 DST HECW2 CLTC AFDN PLEC DMD BSN NOS1 GOLGA3 DYNC1H1 PDCD6IP NRDC CLASP1 KRT19 CORO1B PRDX2 SIPA1 SACM1L PACS1 RNPEP MACF1 EXOC1 TANC1 CGNL1 SNRNP200 | 9.37e-11 | 1431 | 205 | 32 | 37142655 | |
| Pubmed | KIFBP TRIO ZMYM2 TSC2 DBN1 CCDC177 TAOK2 EPS15L1 DST CLTC AFDN BSN NOS1 GOLGA3 DYNC1H1 RGPD2 SIN3B MIA3 PDCD6IP CLASP1 HCN1 CORO1B PRDX2 SIPA1 MACF1 CDK5RAP2 | 1.24e-10 | 963 | 205 | 26 | 28671696 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SART3 KIFBP TMEM120B NDE1 MYO7A SIGMAR1 TSC2 ADCY6 XYLT2 EPS15L1 TEKT2 ZNF638 AFDN PLEC ATL2 DYNC1H1 RUSF1 NRF1 CLASP1 DYNC2H1 UBE3B CORO1B PRDX2 KLC4 DICER1 PACS1 EXOC1 CSPP1 SNRNP200 CDK4 | 2.69e-10 | 1321 | 205 | 30 | 27173435 |
| Pubmed | SART3 UBR1 ADCY6 FREM2 PARP4 DST ZNF638 AFDN MIA3 ARHGEF28 NRDC TTC28 UBE3B DICER1 SACM1L PLCD3 PACS1 TANC1 EIF2AK4 HPS5 TOP3A | 3.56e-10 | 650 | 205 | 21 | 38777146 | |
| Pubmed | SART3 TRIO DBN1 LRP1B TAOK2 PRUNE1 EPS15L1 CLTC AFDN AKT2 PLEC BSN NOS1 RGPD2 MIA3 RARS1 PDCD6IP HCN1 CORO1B PRDX2 PANX2 ATL1 SACM1L SNX25 MACF1 EXOC1 EPB41 | 9.20e-10 | 1139 | 205 | 27 | 36417873 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 ZMYM2 FBXO38 NCAPG CLTC ZNF638 PLEC DYNC1H1 MPI RARS1 PDCD6IP POLA1 RNF213 ACIN1 SNRNP200 | 1.53e-09 | 332 | 205 | 15 | 32786267 |
| Pubmed | DBN1 FBXO38 FAT2 DST OTOF CLTC PLEC DMD FAT3 SNX25 MACF1 CGNL1 SNRNP200 | 1.63e-09 | 234 | 205 | 13 | 36243803 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | SART3 EPPK1 TRIO MYO7A ZMYM2 DBN1 DYNC1H1 SATB2 RARS1 DYNC2H1 NUP42 SLIT1 ACIN1 MACF1 SON | 4.23e-09 | 358 | 205 | 15 | 32460013 |
| Pubmed | SART3 TAOK2 DST CARNS1 PLXNA2 TTC28 MACF1 CDK5RAP2 SNRNP200 MYO16 | 5.85e-09 | 130 | 205 | 10 | 12421765 | |
| Pubmed | ADCY6 ZCCHC14 URB1 DST CAMTA1 ARAP1 TTC28 DICER1 SLIT1 MACF1 HPS5 SNRNP200 | 1.11e-08 | 225 | 205 | 12 | 12168954 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A TSC2 RYR1 FREM2 PARP4 URB1 DST HECW2 CLTC DYNC1H1 SIN3B RARS1 KRT19 POLA1 HCN1 ROR1 MYOM3 RNF213 SNRNP200 PCMT1 | 1.76e-08 | 736 | 205 | 20 | 29676528 |
| Pubmed | MYO10 ADCY6 ZCCHC14 CLTC CAMTA1 DYNC1H1 PLXNA2 TTC28 CLASP1 SACM1L SLIT1 ACIN1 MACF1 SLC39A14 SON | 2.34e-08 | 407 | 205 | 15 | 12693553 | |
| Pubmed | CLTCL1 NDE1 HLA-DRB5 ERMP1 PARP4 EPS15L1 NCAPG MIA2 DHCR24 CLTC ATL2 ITM2B GOLGA3 DYNC1H1 RUSF1 KRT9 PSMF1 MIA3 RARS1 PDCD6IP CLASP1 RNF213 PMVK EXOC1 ADPGK | 3.02e-08 | 1168 | 205 | 25 | 19946888 | |
| Pubmed | DBN1 PRUNE1 EPS15L1 NCAPG CLTC KDM2B AFDN SAP130 DYNC1H1 SIN3B RARS1 TTC28 CORO1B ACIN1 SNRNP200 EPB41 PCMT1 | 3.39e-08 | 549 | 205 | 17 | 38280479 | |
| Pubmed | CLTCL1 URB1 KRT77 CLTC ZNF638 AFDN GOLGA3 KRT9 TFRC ACIN1 SNRNP200 | 3.71e-08 | 202 | 205 | 11 | 24639526 | |
| Pubmed | EPS15L1 FAT1 DST CLTC ZNF638 AFDN GOLGA3 DYNC1H1 KRT9 PDCD6IP TTC28 KRT19 RNF213 FAM83B KIRREL1 CDK5RAP2 CGNL1 SLC39A14 SNRNP200 EPB41 | 4.27e-08 | 777 | 205 | 20 | 35844135 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | EPPK1 EPS15L1 CLTC PLEC DYNC1H1 SIN3B RARS1 CORO1B TFRC TANC1 SNRNP200 EPB41 | 4.62e-08 | 256 | 205 | 12 | 33397691 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPPK1 CLTCL1 RYR1 DST KRT77 CLTC PLEC DYNC1H1 KRT9 MIA3 RARS1 PDCD6IP DYNC2H1 DPP3 IDH1 PRDX2 TFRC MACF1 SNRNP200 MYO16 | 7.88e-08 | 807 | 205 | 20 | 30575818 |
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 9.33e-08 | 63 | 205 | 7 | 29162697 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 KIFBP TRIO DBN1 URB1 NCAPG DHCR24 CLTC AFDN BSN ATL2 ITM2B DYNC1H1 RARS1 PDCD6IP NRDC DYNC2H1 POLA1 PRDX2 DICER1 SACM1L TFRC RNPEP ACIN1 SNRNP200 PCMT1 CDK4 | 9.72e-08 | 1425 | 205 | 27 | 30948266 |
| Pubmed | TRIO DST KRT77 CLTC AFDN PLEC DYNC1H1 KRT19 POLA1 TFRC SLC39A14 PCMT1 | 1.43e-07 | 284 | 205 | 12 | 29459677 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 2.02e-07 | 3 | 205 | 3 | 15744052 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TRIO TSC2 ZCCHC14 DST KRT77 AFDN PLEC ARHGEF28 PDCD6IP TTC28 CLASP1 KRT19 KLC4 FAM83B NKD2 MACF1 TANC1 CGNL1 CSPP1 EPB41 | 2.22e-07 | 861 | 205 | 20 | 36931259 |
| Pubmed | DBN1 CLTC AFDN PLEC DYNC1H1 ARAP1 KRT9 RARS1 PDCD6IP KRT19 CORO1B PRDX2 SIPA1 TFRC MACF1 SNRNP200 EPB41 PCMT1 | 2.45e-07 | 707 | 205 | 18 | 19738201 | |
| Pubmed | RELN EPS15L1 DST ZNF638 PLEC GOLGA3 DYNC1H1 MIA3 SIPA1 PACS1 ACIN1 MACF1 EXOC1 | 2.61e-07 | 360 | 205 | 13 | 33111431 | |
| Pubmed | NDE1 TSC2 CLTC AFDN DYNC1H1 KRT9 CLASP1 KLC4 ACIN1 SNRNP200 SON | 3.89e-07 | 255 | 205 | 11 | 15324660 | |
| Pubmed | SART3 EPPK1 URB1 DST CLTC ZNF638 AFDN PLEC DYNC1H1 PDCD6IP POLA1 DICER1 RNPEP ACIN1 MACF1 SNRNP200 SON | 3.94e-07 | 653 | 205 | 17 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 UBR1 URB1 NCAPG DST CLTC ZNF638 AFDN PLEC DYNC1H1 RARS1 PDCD6IP POLA1 CORO1B PRDX2 TFRC PLCD3 POLR3B ACIN1 MACF1 EXOC1 TANC1 SNRNP200 PCMT1 SON | 4.80e-07 | 1353 | 205 | 25 | 29467282 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NDE1 ZMYM2 CLTC KDM2B BSN KRT9 TTC28 CLASP1 KRT19 DYNC2H1 NUP42 FAM83B MACF1 TANC1 CGNL1 TOP3A | 4.90e-07 | 588 | 205 | 16 | 38580884 |
| Pubmed | 5.17e-07 | 209 | 205 | 10 | 36779422 | ||
| Pubmed | ZNF638 SIN3B MIA3 TTC28 ROR1 NUP42 FAM83B NKD2 KIRREL1 MACF1 TANC1 | 5.28e-07 | 263 | 205 | 11 | 34702444 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 6.07e-07 | 120 | 205 | 8 | 31413325 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | ERMP1 CLTC PLEC DYNC1H1 KRT9 RARS1 TTC28 KRT19 RNF213 TFRC SNRNP200 | 6.36e-07 | 268 | 205 | 11 | 33024031 |
| Pubmed | EPPK1 TRIO MYO10 FAT1 DST CLTC PLEC GOLGA3 DYNC1H1 TENT5A MACF1 SON | 7.52e-07 | 332 | 205 | 12 | 37433992 | |
| Pubmed | iNOS is not responsible for RyR1Â S-nitrosylation in mdx mice with truncated dystrophin. | 8.04e-07 | 4 | 205 | 3 | 32693782 | |
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 8954775 | ||
| Pubmed | Reelin controls position of autonomic neurons in the spinal cord. | 8.04e-07 | 4 | 205 | 3 | 10880573 | |
| Pubmed | 8.80e-07 | 126 | 205 | 8 | 24319055 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | MYO10 DBN1 CLTC PLEC DYNC1H1 PDCD6IP CORO1B SACM1L TFRC MACF1 | 1.50e-06 | 235 | 205 | 10 | 28378594 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPPK1 MIA2 CLTC PLEC CAMTA1 BSN SAP130 DYNC1H1 ARAP1 PDCD6IP TEX14 CBFA2T2 SON | 1.90e-06 | 430 | 205 | 13 | 35044719 |
| Pubmed | TRIO ZCCHC14 ZNF638 AKT2 ATL2 RUSF1 MIA3 TTC28 CLASP1 RNF213 CORO1B DICER1 ATL1 TFRC POLR3B KIRREL1 TANC1 | 1.91e-06 | 733 | 205 | 17 | 34672954 | |
| Pubmed | Sarcolemma-localized nNOS is required to maintain activity after mild exercise. | 2.00e-06 | 5 | 205 | 3 | 18953332 | |
| Pubmed | A novel mode of tangential migration of cortical projection neurons. | 2.00e-06 | 5 | 205 | 3 | 16901480 | |
| Pubmed | Differing roles of mitochondrial nitric oxide synthase in cardiomyocytes and urothelial cells. | 2.00e-06 | 5 | 205 | 3 | 14684357 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBR1 EPPK1 SIGMAR1 EPS15L1 NCAPG CLTC AFDN ATL2 SIN3B PSMF1 PDCD6IP CLASP1 RNF213 CORO1B IDH1 PRDX2 SACM1L TFRC ACIN1 EXOC1 SLC39A14 EPB41 PCMT1 SON | 2.02e-06 | 1367 | 205 | 24 | 32687490 |
| Pubmed | 2.41e-06 | 65 | 205 | 6 | 34645483 | ||
| Pubmed | ZMYM2 BMP4 DST AFDN PLEC SAP130 DYNC1H1 PDCD6IP TENT5A PLCD3 RNPEP CSPG4 ABTB1 MACF1 SON | 2.65e-06 | 591 | 205 | 15 | 15231748 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | B3GALNT1 SIGMAR1 FKBP9 TMTC2 TSC2 ERMP1 LRP1B XYLT2 FAT1 MIA2 ITM2B RUSF1 MIA3 RNF213 PRDX2 SACM1L TFRC CGREF1 CSPG4 KIRREL1 SLC39A14 ADPGK | 2.82e-06 | 1201 | 205 | 22 | 35696571 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.48e-06 | 202 | 205 | 9 | 33005030 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TRIO NDE1 LRP1B EPS15L1 AFDN PLEC DYNC1H1 KRT9 MIA3 TTC28 KRT19 CORO1B KLC4 FAM83B TANC1 CGNL1 EPB41 PCMT1 | 3.53e-06 | 853 | 205 | 18 | 28718761 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 EPPK1 TSC2 NCAPG MIA2 DHCR24 CLTC ZNF638 PLEC DYNC1H1 KRT9 RARS1 PDCD6IP NRDC CLASP1 POLA1 PRDX2 TFRC RNPEP MACF1 SNRNP200 GPN3 PCMT1 SON | 3.63e-06 | 1415 | 205 | 24 | 28515276 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 ZMYM2 DBN1 ADCY6 FBXO38 EPS15L1 CLTC ZNF638 KDM2B AFDN PLEC CLASP1 PACS1 CBFA2T2 ACIN1 SNRNP200 SON | 3.93e-06 | 774 | 205 | 17 | 15302935 |
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 3.98e-06 | 6 | 205 | 3 | 12783884 | |
| Pubmed | 3.98e-06 | 6 | 205 | 3 | 19589776 | ||
| Pubmed | SART3 CLTCL1 DBN1 ADCY6 CHRNB3 DST MIA2 KRT77 CLTC TTLL1 PLEC DMD BSN PLXNA2 RGPD2 KRT19 TEX14 TFRC SNX25 CSPG4 ACIN1 MACF1 MYH15 EIF2AK4 | 5.00e-06 | 1442 | 205 | 24 | 35575683 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SIGMAR1 ERMP1 ADCY6 FAT1 DHCR24 ATL2 ITM2B RUSF1 CLASP1 DYNC2H1 NLRX1 ROR1 RNF213 IDH1 DICER1 RNPEP MACF1 SLC39A14 ADPGK CDH16 | 5.39e-06 | 1061 | 205 | 20 | 33845483 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPPK1 DBN1 DST CLTC PLEC DYNC1H1 RARS1 PDCD6IP PRDX2 RNPEP ACIN1 SNRNP200 SON | 5.85e-06 | 477 | 205 | 13 | 31300519 |
| Pubmed | 6.94e-06 | 7 | 205 | 3 | 16059920 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DBN1 EPS15L1 DST AFDN PLEC GOLGA3 RARS1 CORO1B IDH1 FAM83B MACF1 TANC1 EPB41 PCMT1 | 7.54e-06 | 565 | 205 | 14 | 25468996 |
| Pubmed | RELN TRIO ZMYM2 TSC2 LRP1B EPS15L1 DST MIA2 OTOF CLTC AFDN PLEC GOLGA3 DYNC1H1 TTC28 HCN1 NR4A2 NUP42 POLR3B MACF1 EXOC1 SNRNP200 | 8.21e-06 | 1285 | 205 | 22 | 35914814 | |
| Pubmed | TRIO RYR1 PARP4 DST CLTC PLEC COL6A3 MYOM3 MACF1 CDK5RAP2 EXOC1 ADPGK SON | 9.07e-06 | 497 | 205 | 13 | 23414517 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SIGMAR1 ZMYM2 MIA2 DHCR24 CLTC AFDN PLEC ATL2 RUSF1 MIA3 RARS1 CLASP1 ATL1 SACM1L TFRC NKD2 CSPG4 KIRREL1 SLC39A14 SNRNP200 ADPGK | 9.98e-06 | 1203 | 205 | 21 | 29180619 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | KIFBP EPPK1 PARP4 NCAPG ZNF638 PLEC DYNC1H1 ARAP1 PDCD6IP CLASP1 ACIN1 MACF1 EXOC1 SNRNP200 | 1.05e-05 | 582 | 205 | 14 | 20467437 |
| Pubmed | 1.14e-05 | 24 | 205 | 4 | 19876815 | ||
| Pubmed | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. | 1.16e-05 | 50 | 205 | 5 | 24769233 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 URB1 DST KRT77 CLTC ZNF638 AFDN PLEC DYNC1H1 RARS1 PDCD6IP DICER1 FAM83B TFRC ACIN1 MACF1 SNRNP200 PCMT1 SON | 1.17e-05 | 1024 | 205 | 19 | 24711643 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 ZMYM2 DBN1 PRUNE1 EPS15L1 DST ZNF638 SIN3B CORO1B IDH1 PRDX2 ACIN1 MACF1 CGNL1 SNRNP200 EPB41 PCMT1 SON | 1.21e-05 | 934 | 205 | 18 | 33916271 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KIFBP SIGMAR1 TSC2 TAOK2 URB1 NCAPG DHCR24 CLTC ITM2B DYNC1H1 MIA3 RARS1 PDCD6IP DYNC2H1 SACM1L TFRC KIRREL1 CDK4 | 1.35e-05 | 942 | 205 | 18 | 31073040 |
| Pubmed | KIFBP TSC2 DBN1 DST AFDN MIA3 TTC28 CLASP1 KLC4 FAM83B KIRREL1 CSPP1 | 1.53e-05 | 446 | 205 | 12 | 24255178 | |
| Pubmed | Murine craniofacial development requires Hdac3-mediated repression of Msx gene expression. | 1.58e-05 | 26 | 205 | 4 | 23506836 | |
| Pubmed | 1.61e-05 | 90 | 205 | 6 | 15033168 | ||
| Pubmed | exma: an X-linked insertional mutation that disrupts forebrain and eye development. | 1.65e-05 | 9 | 205 | 3 | 11956759 | |
| Pubmed | 1.65e-05 | 9 | 205 | 3 | 15236237 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 NDE1 ZMYM2 FBXO38 EPS15L1 URB1 CLTC ATL2 DYNC1H1 ARAP1 RGPD2 PDCD6IP CLASP1 FAM83B TFRC PACS1 CDK5RAP2 SNRNP200 TOP3A PCMT1 | 1.84e-05 | 1155 | 205 | 20 | 20360068 |
| Pubmed | 1.86e-05 | 55 | 205 | 5 | 33067418 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.86e-05 | 55 | 205 | 5 | 19468303 | |
| Pubmed | 2.35e-05 | 10 | 205 | 3 | 16615126 | ||
| Pubmed | Single-cell multiomics decodes regulatory programs for mouse secondary palate development. | 2.35e-05 | 10 | 205 | 3 | 38280850 | |
| Pubmed | SART3 EPPK1 ERMP1 DHCR24 CLTC AFDN PLEC DYNC1H1 KRT9 RARS1 KRT19 IDH1 ACIN1 MACF1 SNRNP200 | 2.36e-05 | 711 | 205 | 15 | 33022573 | |
| Pubmed | 2.62e-05 | 59 | 205 | 5 | 26371508 | ||
| Pubmed | SART3 NDE1 ZMYM2 ERMP1 TAOK2 URB1 DST DHCR24 KDM2B AFDN ITM2B SIN3B RARS1 CLASP1 DICER1 FAM83B PLCD3 NCBP2 CGREF1 MACF1 TANC1 EPB41 SON | 2.82e-05 | 1497 | 205 | 23 | 31527615 | |
| Pubmed | MYO7A ZMYM2 RYR1 MEPE PARP4 KDM2B BSN SATB2 PDCD6IP TTC28 PRICKLE1 DYNC2H1 CDK5RAP2 CSPP1 | 2.89e-05 | 638 | 205 | 14 | 31182584 | |
| Pubmed | EPPK1 TRIO SIGMAR1 FKBP9 ERMP1 FAT1 DST CLTC DYNC1H1 MIA3 RARS1 PDCD6IP NRDC CORO1B SACM1L TFRC RNPEP MACF1 SLC39A14 ADPGK PCMT1 | 3.02e-05 | 1297 | 205 | 21 | 33545068 | |
| Pubmed | 3.22e-05 | 11 | 205 | 3 | 29604273 | ||
| Pubmed | 3.36e-05 | 151 | 205 | 7 | 17043677 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPPK1 CLTCL1 DBN1 NCAPG CLTC PLEC DYNC1H1 RGPD2 RARS1 PRDX2 SACM1L NCBP2 CDH3 PCMT1 | 3.37e-05 | 647 | 205 | 14 | 26618866 |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 24643800 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 15539558 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 21825026 | ||
| Pubmed | Chronic NOS inhibition actuates endothelial-mesenchymal transformation. | 3.46e-05 | 2 | 205 | 2 | 16963618 | |
| Pubmed | Identification of differentially expressed proteins during human urinary bladder cancer progression. | 3.46e-05 | 2 | 205 | 2 | 15936593 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 9536086 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 15961532 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 11002341 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 21331324 | ||
| Pubmed | Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children. | 3.46e-05 | 2 | 205 | 2 | 16238787 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 11268022 | ||
| Pubmed | Neuronal nitric oxide synthase plays a key role in CNS demyelination. | 3.46e-05 | 2 | 205 | 2 | 17151270 | |
| Interaction | C2CD4B interactions | 4.98e-06 | 44 | 203 | 6 | int:C2CD4B | |
| Interaction | YWHAH interactions | EPPK1 TRIO NDE1 TSC2 ERMP1 ZCCHC14 PTPN4 DST KRT77 ZNF638 AFDN PLEC ARHGEF28 PDCD6IP TTC28 CLASP1 KRT19 SIPA1 KLC4 FAM83B PACS1 NKD2 RNPEP MACF1 TANC1 CGNL1 CSPP1 EPB41 | 6.12e-06 | 1102 | 203 | 28 | int:YWHAH |
| Interaction | GSK3B interactions | UBR1 TRIO TSC2 DBN1 ACVRL1 PRUNE1 DST HECW2 CLTC AKT2 PLEC GOLGA3 MIA3 RARS1 PDCD6IP TTC28 CLASP1 HCN1 DPP3 DICER1 TFRC RNPEP MACF1 TANC1 | 7.51e-06 | 868 | 203 | 24 | int:GSK3B |
| Interaction | TEDC2 interactions | TRIO DST KRT77 CLTC AFDN PLEC DYNC1H1 POLA1 TFRC SLC39A14 PCMT1 | 8.09e-06 | 206 | 203 | 11 | int:TEDC2 |
| Interaction | KCTD13 interactions | SART3 TRIO MYO7A FKBP9 DBN1 CCDC177 EPS15L1 DST HECW2 CLTC AFDN PLEC DMD BSN NOS1 GOLGA3 DYNC1H1 PDCD6IP NRDC CLASP1 KRT19 CORO1B PRDX2 SIPA1 SACM1L PACS1 RNPEP MACF1 EXOC1 TANC1 CGNL1 SNRNP200 | 1.01e-05 | 1394 | 203 | 32 | int:KCTD13 |
| Interaction | RYK interactions | FREM2 DST AFDN ITM2B DYNC1H1 PLXNA2 FAT3 ROR1 TFRC CSPG4 KIRREL1 | 1.06e-05 | 212 | 203 | 11 | int:RYK |
| Interaction | TOP3B interactions | TMEM120B EPPK1 CLTCL1 TRIO MYO7A MYO10 TSC2 RYR1 TAOK2 ZCCHC14 BMP4 EPS15L1 URB1 FAT1 DST AKT2 PLEC DYNC1H1 ARAP1 RARS1 PDCD6IP NRF1 SZT2 NLRX1 UBE3B MYOM3 CORO1B IDUA PLCD3 CSPG4 ACIN1 TANC1 TOP3A | 1.15e-05 | 1470 | 203 | 33 | int:TOP3B |
| Interaction | MAPRE1 interactions | KIFBP TRIO NDE1 MYO10 TENT5C DBN1 TAOK2 DST CLTC PLEC DYNC1H1 CLASP1 NUP42 MACF1 CDK5RAP2 TANC1 CSPP1 | 1.90e-05 | 514 | 203 | 17 | int:MAPRE1 |
| Interaction | PHLPP1 interactions | EPPK1 TSC2 EPS15L1 CLTC PLEC DYNC1H1 SIN3B RARS1 CORO1B TFRC TANC1 SNRNP200 EPB41 | 3.51e-05 | 333 | 203 | 13 | int:PHLPP1 |
| Interaction | CAV1 interactions | TRIO TSC2 DBN1 ADCY6 DST CLTC AFDN ITM2B NOS3 GOLGA3 ROR1 FAM83B TFRC NKD2 ACIN1 KIRREL1 MACF1 ROBO2 SLC39A14 EPB41 | 4.58e-05 | 724 | 203 | 20 | int:CAV1 |
| Interaction | OCLN interactions | TRIO CLEC7A DST MIA2 CLTC AFDN GOLGA3 MIA3 ROR1 FAM83B KIRREL1 MACF1 ROBO2 TANC1 SLC39A14 EPB41 | 4.98e-05 | 500 | 203 | 16 | int:OCLN |
| Interaction | YWHAG interactions | NDE1 TSC2 TAOK2 PTPN4 DST KRT77 CLTC ZNF638 AFDN DYNC1H1 ARHGEF28 PDCD6IP TTC28 CLASP1 KRT19 SIPA1 KLC4 FAM83B PACS1 NKD2 ACIN1 MACF1 TANC1 CGNL1 CSPP1 SNRNP200 EPB41 SON | 5.78e-05 | 1248 | 203 | 28 | int:YWHAG |
| Interaction | GPR182 interactions | SYNJ2BP SIGMAR1 TSC2 ERMP1 URB1 DHCR24 ALDH3B1 ATL2 RUSF1 NLRX1 UBE3B RNF213 SACM1L EXOC1 ADPGK | 6.16e-05 | 455 | 203 | 15 | int:GPR182 |
| Interaction | LGR4 interactions | CLTCL1 URB1 KRT77 CLTC ZNF638 AFDN GOLGA3 KRT9 TFRC ACIN1 SNRNP200 | 7.41e-05 | 262 | 203 | 11 | int:LGR4 |
| Interaction | YWHAB interactions | NDE1 TSC2 PTPN4 DST KRT77 CLTC ZNF638 AFDN ATL2 SAP130 DYNC1H1 ARHGEF28 TTC28 CLASP1 SIPA1 KLC4 FAM83B NKD2 MACF1 TANC1 CGNL1 SNRNP200 EPB41 SON | 9.09e-05 | 1014 | 203 | 24 | int:YWHAB |
| Interaction | RNF123 interactions | MYO7A TSC2 RYR1 FREM2 PARP4 URB1 DST HECW2 CLTC ALDH3B1 DYNC1H1 SIN3B RARS1 KRT19 POLA1 HCN1 ROR1 MYOM3 RNF213 SNRNP200 PCMT1 | 9.28e-05 | 824 | 203 | 21 | int:RNF123 |
| Interaction | MFSD4A interactions | SYNJ2BP SIGMAR1 XYLT2 DHCR24 ATL2 RUSF1 RNF213 SACM1L SLC39A14 ADPGK | 9.88e-05 | 225 | 203 | 10 | int:MFSD4A |
| Interaction | VCAM1 interactions | PTPN4 CLTC AFDN PLEC DYNC1H1 ARAP1 KRT9 RARS1 PDCD6IP KRT19 PRDX2 TFRC MACF1 SNRNP200 PCMT1 | 9.95e-05 | 475 | 203 | 15 | int:VCAM1 |
| Interaction | FBXO43 interactions | 1.02e-04 | 74 | 203 | 6 | int:FBXO43 | |
| Interaction | CDH1 interactions | MYO7A TMTC2 DBN1 EPS15L1 DST AFDN PLEC GOLGA3 KRT9 RARS1 CORO1B IDH1 FAM83B NKD2 MACF1 TANC1 CDH3 EPB41 PCMT1 CDK4 | 1.03e-04 | 768 | 203 | 20 | int:CDH1 |
| Interaction | MAPRE3 interactions | TRIO DBN1 TAOK2 DST TTC28 CLASP1 FAM83B MACF1 CDK5RAP2 TANC1 | 1.18e-04 | 230 | 203 | 10 | int:MAPRE3 |
| Interaction | CAPZA2 interactions | CLTCL1 DBN1 CALHM4 DST CLTC AFDN PLEC ARAP1 CLASP1 CORO1B SIPA1 MACF1 CDK5RAP2 CSPP1 | 1.24e-04 | 430 | 203 | 14 | int:CAPZA2 |
| Interaction | ADAMTS13 interactions | 1.26e-04 | 26 | 203 | 4 | int:ADAMTS13 | |
| Interaction | YWHAZ interactions | NDE1 TENT5C TSC2 PTPN4 DST KRT77 CLTC ZNF638 AFDN PLEC ATL2 NOS1 GOLGA3 DYNC1H1 ARHGEF28 TTC28 CLASP1 PRDX2 SIPA1 KLC4 FAM83B PACS1 NKD2 MACF1 CDK5RAP2 TANC1 CGNL1 EPB41 | 1.48e-04 | 1319 | 203 | 28 | int:YWHAZ |
| Interaction | CHRDL1 interactions | 1.57e-04 | 11 | 203 | 3 | int:CHRDL1 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.16e-07 | 8 | 137 | 4 | 939 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.73e-05 | 115 | 137 | 7 | 769 | |
| GeneFamily | Cadherin related | 2.68e-04 | 17 | 137 | 3 | 24 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.55e-04 | 50 | 137 | 4 | 1293 | |
| GeneFamily | EF-hand domain containing | 1.41e-03 | 219 | 137 | 7 | 863 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN MYO10 CARMIL3 DST CLTC DYNC1H1 MIA3 TTC28 DYNC2H1 MACF1 ROBO2 SON | 1.25e-10 | 195 | 205 | 12 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN CARMIL3 DST CLTC DYNC1H1 MIA3 TTC28 DYNC2H1 MACF1 ROBO2 SON | 1.88e-09 | 195 | 205 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYO10 BMP4 DST BSN COL6A3 DYNC2H1 CBFA2T2 MACF1 SLC39A14 MYO16 | 2.84e-08 | 197 | 205 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-07 | 184 | 205 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-07 | 184 | 205 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-07 | 184 | 205 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 2.24e-07 | 187 | 205 | 9 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.79e-07 | 192 | 205 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | FKBP9 SAP130 GOLGA3 DYNC1H1 COL6A3 UBE3B SHOX2 PMVK SLC39A14 | 2.92e-07 | 193 | 205 | 9 | 1b29525c5936d1b779253b8c20f059fa091c6127 |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.92e-07 | 193 | 205 | 9 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.92e-07 | 193 | 205 | 9 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-07 | 194 | 205 | 9 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.05e-07 | 194 | 205 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.47e-07 | 197 | 205 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.94e-07 | 200 | 205 | 9 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.05e-06 | 166 | 205 | 8 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-06 | 170 | 205 | 8 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-06 | 170 | 205 | 8 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-06 | 174 | 205 | 8 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-06 | 126 | 205 | 7 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.96e-06 | 126 | 205 | 7 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.19e-06 | 183 | 205 | 8 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 183 | 205 | 8 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.47e-06 | 186 | 205 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.89e-06 | 190 | 205 | 8 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 3.13e-06 | 192 | 205 | 8 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-06 | 193 | 205 | 8 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-06 | 193 | 205 | 8 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-06 | 193 | 205 | 8 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 194 | 205 | 8 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 194 | 205 | 8 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.51e-06 | 195 | 205 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.51e-06 | 195 | 205 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-06 | 196 | 205 | 8 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-06 | 196 | 205 | 8 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-06 | 197 | 205 | 8 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.78e-06 | 197 | 205 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.93e-06 | 198 | 205 | 8 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 198 | 205 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.23e-06 | 200 | 205 | 8 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.23e-06 | 200 | 205 | 8 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Sepsis-URO-Myeloid-cDC1|URO / Disease, condition lineage and cell class | 4.23e-06 | 200 | 205 | 8 | c5ca81218be40b30e2f9252c1a004cb95d988447 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.14e-06 | 159 | 205 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 164 | 205 | 7 | 7dbe34a98a3b475c1ba678db8a5494c0c6a91e2d | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 164 | 205 | 7 | febcb8f8b305aa94e21131fa83d2890f7a6838fc | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 165 | 205 | 7 | 1e89154114327650df39befb2c56d0379ea6a221 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 168 | 205 | 7 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 169 | 205 | 7 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 175 | 205 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 177 | 205 | 7 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 179 | 205 | 7 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 2.04e-05 | 180 | 205 | 7 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 2.27e-05 | 183 | 205 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 184 | 205 | 7 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-05 | 184 | 205 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 184 | 205 | 7 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 184 | 205 | 7 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 184 | 205 | 7 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 2.35e-05 | 184 | 205 | 7 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-05 | 184 | 205 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.43e-05 | 185 | 205 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 2.43e-05 | 185 | 205 | 7 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 185 | 205 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.43e-05 | 185 | 205 | 7 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 186 | 205 | 7 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 186 | 205 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.61e-05 | 187 | 205 | 7 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.61e-05 | 187 | 205 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.61e-05 | 187 | 205 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 2.70e-05 | 188 | 205 | 7 | 411d4dd5c9dee7ebd8db352640cf009e7b033ba9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-05 | 188 | 205 | 7 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.79e-05 | 189 | 205 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 189 | 205 | 7 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.79e-05 | 189 | 205 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.79e-05 | 189 | 205 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 2.79e-05 | 189 | 205 | 7 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 189 | 205 | 7 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 189 | 205 | 7 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.89e-05 | 190 | 205 | 7 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.89e-05 | 190 | 205 | 7 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-05 | 190 | 205 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.99e-05 | 191 | 205 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.09e-05 | 192 | 205 | 7 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 3.09e-05 | 192 | 205 | 7 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-05 | 192 | 205 | 7 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.19e-05 | 193 | 205 | 7 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.19e-05 | 193 | 205 | 7 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.19e-05 | 193 | 205 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.19e-05 | 193 | 205 | 7 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.19e-05 | 193 | 205 | 7 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.19e-05 | 193 | 205 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.19e-05 | 193 | 205 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.19e-05 | 193 | 205 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.19e-05 | 193 | 205 | 7 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.52e-06 | 50 | 124 | 7 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | EPPK1 NDE1 TSC2 PRUNE1 SATB2 OXLD1 ARHGEF28 TTC28 NCBP2 KIRREL1 CDH3 | 1.58e-06 | 196 | 203 | 11 | 5827_DN |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; PC3; HT_HG-U133A | CLTCL1 BAAT XYLT2 ZCCHC14 EPS15L1 URB1 MIA2 ROR1 SHOX2 PRDX2 SNRNP200 | 1.75e-06 | 198 | 203 | 11 | 5108_UP |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A | NDE1 PRUNE1 XYLT2 ZCCHC14 PLEC DYNC2H1 NR4A2 GSAP DMC1 CDK5RAP2 | 1.21e-05 | 198 | 203 | 10 | 3219_DN |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | TMEM120B ADCY6 MIA2 ITM2B RUSF1 SIN3B RARS1 GSAP CDK5RAP2 TOP3A | 1.32e-05 | 200 | 203 | 10 | 1682_DN |
| Drug | cyclopropavir | 1.85e-05 | 37 | 203 | 5 | CID003006048 | |
| Drug | SK&F 82958 | 2.14e-05 | 19 | 203 | 4 | ctd:C071262 | |
| Drug | Miniglucagon | 2.66e-05 | 20 | 203 | 4 | CID003080901 | |
| Drug | Air Pollutants, Occupational | NAPEPLD CD244 CARMIL3 NAIP CLEC7A TENT5C TLR8 FBXO38 PARP4 TRANK1 ARAP1 NR4A2 OVOS2 IDH1 ACIN1 EXOC1 GPN3 TOP3A CDK4 | 2.86e-05 | 725 | 203 | 19 | ctd:D000395 |
| Drug | bromodeoxyuridine | TIGD7 RELN NDE1 MYO7A BMP4 DMD NOS1 NRF1 KRT19 POLA1 CSPG4 ACIN1 CDK4 | 3.54e-05 | 376 | 203 | 13 | CID000006035 |
| Drug | NSC 208734 | 3.81e-05 | 70 | 203 | 6 | CID000002008 | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A | 4.62e-05 | 186 | 203 | 9 | 2426_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.68e-05 | 191 | 203 | 9 | 3905_UP | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 5.68e-05 | 191 | 203 | 9 | 4647_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.41e-05 | 194 | 203 | 9 | 7322_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 6.66e-05 | 195 | 203 | 9 | 3923_DN | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; PC3; HT_HG-U133A | 6.93e-05 | 196 | 203 | 9 | 6684_DN | |
| Drug | 4-toluidine | RELN ERMP1 NRF1 TTC28 DYNC2H1 PRDX2 KLC4 TFRC RNPEP ABTB1 CGNL1 EPB41 | 7.08e-05 | 347 | 203 | 12 | ctd:C029370 |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; HL60; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 1848_UP | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 7332_DN | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 5415_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; PC3; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 4079_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 6949_DN | |
| Drug | gentamicin | 7.50e-05 | 198 | 203 | 9 | CID000003467 | |
| Drug | rapamycin; Up 200; 0.1uM; MCF7; HG-U133A | 7.79e-05 | 199 | 203 | 9 | 326_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 2858_DN | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 6033_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 7330_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 7471_DN | |
| Drug | diarylpropionitrile | 7.86e-05 | 26 | 203 | 4 | ctd:C492519 | |
| Drug | L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide | 7.91e-05 | 2 | 203 | 2 | DB01821 | |
| Drug | Badg | 7.91e-05 | 2 | 203 | 2 | CID000125951 | |
| Drug | S-Ethyl-N-Phenyl-Isothiourea | 7.91e-05 | 2 | 203 | 2 | DB03707 | |
| Drug | N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE | 7.91e-05 | 2 | 203 | 2 | DB08018 | |
| Drug | N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine | 7.91e-05 | 2 | 203 | 2 | DB08019 | |
| Drug | L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide | 7.91e-05 | 2 | 203 | 2 | DB02077 | |
| Drug | N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine | 7.91e-05 | 2 | 203 | 2 | DB02027 | |
| Drug | piperidine hydrochloride | 7.91e-05 | 2 | 203 | 2 | CID000022465 | |
| Drug | Nitroarginine | 7.91e-05 | 2 | 203 | 2 | DB04223 | |
| Drug | acetylaminophenylarsine oxide | 8.00e-05 | 10 | 203 | 3 | CID006337999 | |
| Disease | periodontitis | EPPK1 LRP1B FBXO38 OTOF PLEC DMD CAMTA1 ARAP1 PARP15 KRT9 FAT3 ROBO2 | 4.06e-08 | 223 | 198 | 12 | EFO_0000649 |
| Disease | epilepsy (implicated_via_orthology) | 1.52e-05 | 163 | 198 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 3.06e-05 | 27 | 198 | 4 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Intellectual Disability | KIFBP TRIO ZMYM2 DYNC1H1 RARS1 NR4A2 LGI4 ATL1 PACS1 POLR3B ACIN1 MACF1 | 5.39e-05 | 447 | 198 | 12 | C3714756 |
| Disease | hereditary spastic paraplegia 3A (implicated_via_orthology) | 1.34e-04 | 3 | 198 | 2 | DOID:0110791 (implicated_via_orthology) | |
| Disease | Intestinal Perforation | 1.34e-04 | 3 | 198 | 2 | C0021845 | |
| Disease | response to radiation, Urinary retention | 1.89e-04 | 17 | 198 | 3 | GO_0009314, HP_0000016 | |
| Disease | neutrophil measurement | 2.02e-04 | 177 | 198 | 7 | EFO_0803548 | |
| Disease | age at menarche | B3GALNT1 MYO10 ERMP1 LRP1B ADCY8 DST BSN SATB2 TTC28 NR4A2 FAM83B GALNT9 SLIT1 | 2.04e-04 | 594 | 198 | 13 | EFO_0004703 |
| Disease | Muscular Atrophy, Spinal, Type II | 2.66e-04 | 4 | 198 | 2 | C0393538 | |
| Disease | Muscular atrophy, spinal, infantile chronic form | 2.66e-04 | 4 | 198 | 2 | C2931358 | |
| Disease | Juvenile Spinal Muscular Atrophy | 2.66e-04 | 4 | 198 | 2 | C0152109 | |
| Disease | HMN (Hereditary Motor Neuropathy) Proximal Type I | 2.66e-04 | 4 | 198 | 2 | C0043116 | |
| Disease | tuberous sclerosis (is_marker_for) | 2.66e-04 | 4 | 198 | 2 | DOID:13515 (is_marker_for) | |
| Disease | Duchenne muscular dystrophy (is_marker_for) | 4.42e-04 | 5 | 198 | 2 | DOID:11723 (is_marker_for) | |
| Disease | Spinal muscular atrophy, Jerash type | 4.42e-04 | 5 | 198 | 2 | C1854023 | |
| Disease | unipolar depression | TRIO MYO10 TSC2 ZCCHC14 FAT1 NALCN ZNF638 DMD CAMTA1 NOS1 PARP15 NRDC DYNC2H1 NR4A2 RNF213 TSPAN33 ZBTB34 ROBO2 SNRNP200 | 5.21e-04 | 1206 | 198 | 19 | EFO_0003761 |
| Disease | bipolar disorder | TAOK2 TRANK1 DHH PLEC ATP8B3 NRF1 CLASP1 MYOM3 PACS1 PMVK SLIT1 INSYN2B | 5.62e-04 | 577 | 198 | 12 | MONDO_0004985 |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 6.60e-04 | 6 | 198 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Lissencephaly | 6.60e-04 | 6 | 198 | 2 | C0266463 | |
| Disease | Lewy body dementia, Lewy body dementia measurement | 6.90e-04 | 26 | 198 | 3 | EFO_0006792, EFO_0006799 | |
| Disease | Seizures, Focal | 6.95e-04 | 104 | 198 | 5 | C0751495 | |
| Disease | diet measurement | TRIO MIER3 LRP1B CHRNB3 TRANK1 DST DHH NALCN HECW2 CAMTA1 NRF1 HCN1 TENT5A LRATD1 NR4A2 ROBO2 MYO16 | 7.54e-04 | 1049 | 198 | 17 | EFO_0008111 |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 9.20e-04 | 7 | 198 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | ventral diencephalon volume measurement | 9.20e-04 | 7 | 198 | 2 | EFO_0010337 | |
| Disease | neuroimaging measurement | RELN CHRNB3 TAOK2 PTPN4 PLEC CAMTA1 PLXNA2 SZT2 FAT3 ROR1 IDUA TFRC CBFA2T2 MACF1 ROBO2 SLC39A14 MYO16 | 9.27e-04 | 1069 | 198 | 17 | EFO_0004346 |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.16e-03 | 31 | 198 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Polydactyly | 1.18e-03 | 117 | 198 | 5 | C0152427 | |
| Disease | Familial pulmonary arterial hypertension | 1.22e-03 | 8 | 198 | 2 | C1701939 | |
| Disease | Unilateral agenesis of kidney | 1.22e-03 | 8 | 198 | 2 | C0266294 | |
| Disease | donor genotype effect measurement, chronic graft versus host disease | 1.22e-03 | 8 | 198 | 2 | EFO_0007892, MONDO_0020547 | |
| Disease | sexual dimorphism measurement | BRPF3 EPPK1 TSC2 ADCY8 TAOK2 TRANK1 ZNF638 PLEC BSN CARNS1 KRT9 TENT5A SIPA1 PACS1 CBFA2T2 SLIT1 MACF1 | 1.34e-03 | 1106 | 198 | 17 | EFO_0021796 |
| Disease | Microlissencephaly | 1.40e-03 | 33 | 198 | 3 | C1956147 | |
| Disease | Bipolar Disorder | 1.52e-03 | 477 | 198 | 10 | C0005586 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.53e-03 | 34 | 198 | 3 | EFO_0009926 | |
| Disease | cerebrospinal fluid biomarker measurement, t-tau measurement | 1.56e-03 | 9 | 198 | 2 | EFO_0004760, EFO_0006794 | |
| Disease | Malignant Neoplasms | 1.76e-03 | 128 | 198 | 5 | C0006826 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.82e-03 | 257 | 198 | 7 | DOID:10652 (is_marker_for) | |
| Disease | platelet component distribution width | TMEM120B TENT5C TRANK1 MIA2 TTLL1 PLEC CAMTA1 NOS3 NRF1 PRDX2 MACF1 EIF2AK4 EPB41 | 1.86e-03 | 755 | 198 | 13 | EFO_0007984 |
| Disease | interleukin 10 measurement | 1.90e-03 | 78 | 198 | 4 | EFO_0004750 | |
| Disease | Pulmonary arterial hypertension | 1.95e-03 | 10 | 198 | 2 | C2973725 | |
| Disease | 5-acetylamino-6-amino-3-methyluracil measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0800951 | |
| Disease | alpha peak frequency measurement, alpha wave measurement, electroencephalogram measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0004357, EFO_0006870, EFO_0006883 | |
| Disease | brain volume measurement | RELN CHRNB3 BMP4 SELENOO CAMTA1 PLXNA2 SZT2 FAT3 PANX2 POLR3B SLC39A14 | 2.40e-03 | 595 | 198 | 11 | EFO_0006930 |
| Disease | sleep apnea | 2.45e-03 | 40 | 198 | 3 | EFO_0003877 | |
| Disease | Pulmonary Hypertension | 2.45e-03 | 40 | 198 | 3 | C0020542 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.52e-03 | 139 | 198 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | high grade glioma (is_marker_for) | 2.82e-03 | 42 | 198 | 3 | DOID:3070 (is_marker_for) | |
| Disease | Oligospermia | 2.83e-03 | 12 | 198 | 2 | C0028960 | |
| Disease | Colorectal Carcinoma | ADCY8 BMP4 FAT1 NCAPG DMD SATB2 NR4A2 CORO1B IDH1 TFRC ACIN1 SNRNP200 | 2.93e-03 | 702 | 198 | 12 | C0009402 |
| Disease | mean reticulocyte volume | TMEM120B FBXO38 ZNF638 AFDN CARNS1 CLASP1 NLRX1 IDUA TFRC GALNT9 CDH3 MYO16 EPB41 | 3.03e-03 | 799 | 198 | 13 | EFO_0010701 |
| Disease | mean corpuscular hemoglobin concentration | TENT5C TSC2 CHRNB3 HECW2 ZNF638 RUSF1 TTC28 CLASP1 CORO1B TFRC NKD2 GALNT9 MACF1 EIF2AK4 MYO16 EPB41 | 3.33e-03 | 1105 | 198 | 16 | EFO_0004528 |
| Disease | cardiomyopathy (biomarker_via_orthology) | 3.33e-03 | 13 | 198 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 3.33e-03 | 13 | 198 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.37e-03 | 447 | 198 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | calcium measurement | HGFAC ZMYM2 LRP1B PLEC NOS1 PARP15 NLRX1 ATL1 MACF1 EIF2AK4 CGNL1 | 3.61e-03 | 628 | 198 | 11 | EFO_0004838 |
| Disease | blood urea nitrogen measurement | 3.63e-03 | 452 | 198 | 9 | EFO_0004741 | |
| Disease | Seizures | 3.64e-03 | 218 | 198 | 6 | C0036572 | |
| Disease | mean platelet volume | TMEM120B NDE1 TENT5C ACVRL1 TRANK1 PLEC CAMTA1 NOS3 ARAP1 NRDC NRF1 TTC28 POLA1 GALNT9 CDK4 | 3.85e-03 | 1020 | 198 | 15 | EFO_0004584 |
| Disease | Malformations of Cortical Development | 3.87e-03 | 14 | 198 | 2 | C1955869 | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 3.87e-03 | 14 | 198 | 2 | C1150929 | |
| Disease | C-C motif chemokine 19 measurement | 3.87e-03 | 14 | 198 | 2 | EFO_0008047 | |
| Disease | Cortical Dysplasia | 3.87e-03 | 14 | 198 | 2 | C0431380 | |
| Disease | Arthritis, Psoriatic | 3.87e-03 | 14 | 198 | 2 | C0003872 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 3.88e-03 | 47 | 198 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 3.89e-03 | 95 | 198 | 4 | C0279626 | |
| Disease | mean fractional anisotropy measurement | 3.89e-03 | 95 | 198 | 4 | EFO_0008399 | |
| Disease | obsolete_red blood cell distribution width | CHRNB3 HECW2 KDM2B AFDN MPI PSMF1 NRF1 TTC28 CLASP1 UBE3B SIPA1 TFRC METTL25B NKD2 CBFA2T2 EIF2AK4 CDH3 MYO16 | 4.37e-03 | 1347 | 198 | 18 | EFO_0005192 |
| Disease | Acute Confusional Senile Dementia | 4.51e-03 | 99 | 198 | 4 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 4.51e-03 | 99 | 198 | 4 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 4.51e-03 | 99 | 198 | 4 | C0750901 | |
| Disease | Presenile dementia | 4.51e-03 | 99 | 198 | 4 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 4.51e-03 | 99 | 198 | 4 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 4.67e-03 | 100 | 198 | 4 | C0276496 | |
| Disease | Generalized seizures | 4.84e-03 | 101 | 198 | 4 | C0234533 | |
| Disease | Clonic Seizures | 4.84e-03 | 101 | 198 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 4.84e-03 | 101 | 198 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 4.84e-03 | 101 | 198 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 4.84e-03 | 101 | 198 | 4 | C0751056 | |
| Disease | Alzheimer's Disease | 4.84e-03 | 101 | 198 | 4 | C0002395 | |
| Disease | Atonic Absence Seizures | 4.84e-03 | 101 | 198 | 4 | C0751123 | |
| Disease | Complex partial seizures | 4.84e-03 | 101 | 198 | 4 | C0149958 | |
| Disease | Single Seizure | 4.84e-03 | 101 | 198 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 4.84e-03 | 101 | 198 | 4 | C3495874 | |
| Disease | Visual seizure | 4.84e-03 | 101 | 198 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 4.84e-03 | 101 | 198 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 4.84e-03 | 101 | 198 | 4 | C0422855 | |
| Disease | Gustatory seizure | 4.84e-03 | 101 | 198 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 4.84e-03 | 101 | 198 | 4 | C0422850 | |
| Disease | Olfactory seizure | 4.84e-03 | 101 | 198 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 4.84e-03 | 101 | 198 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 4.84e-03 | 101 | 198 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 4.84e-03 | 101 | 198 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 4.84e-03 | 101 | 198 | 4 | C4317109 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 4.89e-03 | 51 | 198 | 3 | EFO_0004869, EFO_0004872 | |
| Disease | Absence Seizures | 5.01e-03 | 102 | 198 | 4 | C4316903 | |
| Disease | Convulsions | 5.01e-03 | 102 | 198 | 4 | C4048158 | |
| Disease | Tonic Seizures | 5.01e-03 | 102 | 198 | 4 | C0270844 | |
| Disease | Diabetic Angiopathies | 5.05e-03 | 16 | 198 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 5.05e-03 | 16 | 198 | 2 | C0025945 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YAEQDELDYHRGLLV | 1086 | Q9UKV3 | |
| DSDRQEHQDLGLYHL | 761 | Q13075 | |
| YDSLGLLELDQRTHF | 456 | P31751 | |
| FEGADYESHLLRENT | 981 | P55196 | |
| FLRYDNLNHSGEDFL | 881 | P40145 | |
| QGDDLQSLLFHFLDE | 81 | Q8IWT0 | |
| REQYIPNEEFLHSDL | 166 | P18440 | |
| EAHRSLEQYDQVLDG | 556 | Q9UBC2 | |
| EHLNLLEEDYFGLAI | 241 | P11171 | |
| AENEDALLRHLFQGY | 26 | Q05901 | |
| SQAHYRANEFGEVDL | 46 | Q14032 | |
| QEVDEFHLILEYQAG | 201 | Q9BRR6 | |
| FAQLTLSDHEQRELY | 1511 | Q9Y6Y1 | |
| FGDSYFEELRQQLGH | 266 | Q86VW2 | |
| VSYLAHLVGDQDQFD | 421 | Q9H4A4 | |
| TNEDLLRGRLVYQHD | 961 | Q6UVK1 | |
| QRQDHELQALEAIYG | 21 | Q9P2K8 | |
| GERNAYLKEQHIETF | 536 | O43306 | |
| QETGQLLEHRFDYIF | 171 | P43353 | |
| NVGTAEELYRLDSLH | 161 | Q9BR76 | |
| EAARDYGLQLHLVES | 411 | A5YM72 | |
| HLYRTLEEFEEDFNL | 646 | Q9ULD4 | |
| EHGSLYDFLQRQTLE | 281 | P37023 | |
| LDHGLYQFLEEKDRA | 381 | Q3MIX3 | |
| SLNDHLGQVEYIFSD | 481 | O60423 | |
| LVLGAHQQQYREDLF | 526 | O43246 | |
| LEHAFNIARYQLGIE | 196 | P11532 | |
| HDYDQSGQLDGLELL | 81 | Q99674 | |
| RFNVDHDAVLDNVLY | 176 | Q14565 | |
| DFLEYDQEHIRFIDN | 1441 | Q9UPY3 | |
| LYRLQSGEEEEEQIH | 86 | P12644 | |
| EFDALQARDYLEHIT | 106 | Q7Z2K6 | |
| IHDLETELEGYQNFI | 1116 | Q96SN8 | |
| AKFHLDRVENDGENY | 216 | O75901 | |
| HLDLTEQDYFGLQLA | 61 | P29074 | |
| QLQEYQHSLERLREG | 1496 | Q8N1W1 | |
| GRQDSLNDYLDAIEH | 411 | Q9P2P5 | |
| HLEFLGQLRQYDEDG | 146 | Q9NSK0 | |
| RDEIDLHALYQAGQL | 86 | Q86TP1 | |
| QVRYSLLDHGEGNFD | 961 | Q14517 | |
| LQEVHFLVYTNDDEG | 241 | Q460N3 | |
| EIATYRSLLEGQEDH | 376 | P08727 | |
| RSLLEGQEDHYNNLS | 381 | P08727 | |
| NGNEIHTLDFIYNED | 231 | Q9NZR2 | |
| LHRDIYNQEEDLRFD | 56 | Q30154 | |
| ELSQYRDQHFRGDNE | 16 | P52298 | |
| TDRIENIDHLGFFIY | 206 | Q9Y287 | |
| LHDQEEYGAALIRNN | 136 | Q9NQ76 | |
| IETYHNLLEGGQEDF | 451 | P35527 | |
| ILEHGGDLNIVDDQY | 241 | Q9Y6X6 | |
| VNDLYEDLRDGHNLI | 56 | Q03001 | |
| RLDHLEEVVYNQLNG | 66 | Q9HCQ5 | |
| QLHLYDTRGLQEGVE | 56 | Q9NYS0 | |
| ELAAGQVVYQHDDRD | 511 | Q5SZK8 | |
| DHGTYNDLISQLEEL | 406 | Q9UPZ3 | |
| GEHRDYLSDSELNQL | 3006 | Q9UPA5 | |
| EHLLYGDIIRQDFLD | 136 | O75752 | |
| TIYHAEDNREFNLLD | 181 | Q8ND23 | |
| IEHGLEAYQEFLVQE | 36 | Q5T0W9 | |
| LNGGYQDELVDHRLT | 326 | O43439 | |
| HEGALETLLRYYDQI | 61 | Q8WUM4 | |
| RAHVDSNLQFEYIDD | 1026 | O75051 | |
| IVSGNELEYFDLNHF | 601 | Q9NYQ8 | |
| DRNHEDIFNYFDLLE | 621 | Q9HCI6 | |
| LQHYCERDNLIGEET | 861 | Q1MSJ5 | |
| KQHGREDLLYAFEDQ | 271 | Q16656 | |
| LLAGLEHEEREEFYL | 266 | Q9HD67 | |
| RQHALAEGLTEEEYQ | 76 | Q9NY33 | |
| LHQGEIRQDSLYEAG | 156 | Q96KN4 | |
| GQAVELFDEEFRHLY | 276 | Q86UY5 | |
| LDRLLYLQEQGFHAE | 426 | Q96FB5 | |
| FSGHRLELLAAYEEV | 6 | Q16643 | |
| GTHTRDNEQALYELL | 241 | Q7Z3K6 | |
| ELLHLYFNELSSEGR | 866 | Q86UT6 | |
| ALIRDYEDGILHENE | 1131 | Q9UKK3 | |
| DHVLFYLENVFGRAD | 1381 | Q6IE36 | |
| DALQTHYDELQARLG | 741 | Q08378 | |
| HYDELQARLGELQGE | 746 | Q08378 | |
| NSDLLYQELHVDSVG | 311 | Q04756 | |
| EDIFGELLLQLHQQY | 231 | P34949 | |
| TERRNHYLDLAGIEN | 241 | Q969F2 | |
| LRLVQAFQYTDEHGE | 156 | P32119 | |
| ERNEFLLLHAFYENN | 786 | P09884 | |
| DLYEDLRDGHNLISL | 101 | Q9UPN3 | |
| VEYADRLLQHFQDGG | 101 | Q5BKU9 | |
| LHGQDLFYEDEDLRK | 296 | Q6VY07 | |
| ILRDDFDSYHQLQLN | 201 | P78509 | |
| DDNRYHEDIFGVTLR | 1391 | P29475 | |
| DQQRYHEDIFGLTLR | 1151 | P29474 | |
| EELRLEYHNFLTSNN | 156 | O15504 | |
| RLQELELDHGASGYN | 496 | Q96MT3 | |
| ETLHLGYVDEFLLQS | 351 | Q6PIJ6 | |
| GEVLLEEFSEYIHAQ | 506 | O95302 | |
| IHYGRDNQNLDILLF | 2616 | Q8NCM8 | |
| NDYESLHVLNVERNG | 41 | A4D1B5 | |
| EHRYQGKIFDEENIL | 436 | O60741 | |
| ELDLHSYDLGIENRD | 36 | O75874 | |
| EEKLRSQLYQGDFVH | 71 | Q8NHM5 | |
| QHIDFAIQYGEDLEF | 246 | Q9UHW5 | |
| DLQHLQLFTEYGRLA | 186 | Q8WXF7 | |
| VQQEYGVHLRLASDD | 11 | Q0VF96 | |
| LVFEHVDQDLRTYLD | 91 | P11802 | |
| AQDSLHYEGRALDIT | 136 | O43323 | |
| RQENHFVEGLLYSLD | 261 | Q15392 | |
| GEEHFQLVREFLYDV | 51 | P12111 | |
| GVLYTAERLDHEAQD | 1516 | Q8TDW7 | |
| EDDLQHLQLFTEYGR | 211 | Q8NHH9 | |
| DLQGHYSFLGNRVDE | 286 | Q5JW98 | |
| EEEREQFLYHLLSLN | 906 | Q6ZUT9 | |
| FTHLDGYLDLLRENQ | 111 | P35475 | |
| LENESLLAGYTHERI | 111 | Q8N7U6 | |
| YDAEFQHFLRGNEIV | 3901 | Q14204 | |
| GFLIEDAHESRYETN | 261 | Q96J84 | |
| QDEFIRQYKHFEGLI | 851 | Q9NV70 | |
| ASLGRAQENYEHLVE | 536 | Q9NQR7 | |
| QDGLDREHVYDLFEK | 161 | Q15020 | |
| DLFLGNYSVDELESH | 496 | Q9NTJ5 | |
| ASFLQDLIHRYGEGD | 41 | Q15043 | |
| LDRVYGIENQDFLLH | 2506 | P21817 | |
| NLTYLDEEVDINGTH | 181 | Q9BZW8 | |
| QDYDITQLHRGLEAR | 711 | P22223 | |
| EARELFLLGQHYVFE | 391 | Q96EK5 | |
| EYLLQVRAQNSHGED | 301 | O75309 | |
| LNLDDYIDAEHLGDF | 106 | Q92530 | |
| LNNNAIFEIEGLHYL | 96 | A6NJI9 | |
| YTLLDEHQDLNEGLG | 546 | Q9HC10 | |
| LVFDNLELYGEAHEL | 1011 | Q9HC10 | |
| LHINTLYEAREEEDG | 626 | Q96RD6 | |
| FERHTLLEYLLGEGN | 206 | Q96RQ9 | |
| LEEELERTIHSYQGQ | 1046 | Q96PC5 | |
| SGDDTQHIQQFYDLL | 396 | P43354 | |
| FELQQLVEGHQESYL | 341 | Q96GQ5 | |
| EFAGYDVLRLNHVGD | 226 | P54136 | |
| YLDSEGLRHQDDFDV | 3151 | Q5T011 | |
| AYALELLFDQLHEGA | 66 | P22061 | |
| GTLRNDSLEAQLHEY | 16 | Q8IWB6 | |
| EGEFQELQETHRIYK | 16 | A0PK00 | |
| DGGRDDFHNYNVEEL | 126 | Q5JRA6 | |
| DFHNYNVEELLGFLE | 131 | Q5JRA6 | |
| HLQYLFIEDNEIGSI | 101 | Q8N135 | |
| AHRFLGLLYELEENT | 61 | P0DJD1 | |
| LQFEDILANTFYREH | 286 | Q9H3E2 | |
| LLHQDAVDLFRNAGY | 76 | P57105 | |
| ELLGSLEIDHTQYRF | 756 | Q9Y2K3 | |
| EIIDQDLYERLEHGQ | 576 | P58107 | |
| GSLEYDNREEHAEFV | 71 | Q9UPW6 | |
| EIAQLARQYAGLDHE | 41 | Q99720 | |
| LAEEFDAEFQRHYLQ | 406 | Q9BVL4 | |
| HLIFVYEDRQILEDA | 651 | O75182 | |
| QLNELERLFDETHYP | 151 | O60902 | |
| TFSEQQLDLYHGRGE | 641 | Q96FS4 | |
| EYIILIDGLNEAEFH | 586 | Q9C0D5 | |
| RDQAQYGLTDEVHQL | 331 | Q9UIF3 | |
| EHEQDSALREQLSGY | 481 | Q9UL54 | |
| YAQEHGLNFQRLLDT | 51 | Q15126 | |
| LTHDVELNLDYERYN | 601 | P02786 | |
| HLEGARFQEQSQLLY | 1696 | O60287 | |
| YGDFEEAFDHLQNRL | 216 | Q5VWP2 | |
| YDDFLQRLLEQGIHS | 101 | Q969K4 | |
| GLQEELQELRERYHF | 221 | Q96JN2 | |
| RLYLFGLESAEQAHE | 826 | Q96P48 | |
| GLLQRALEHFTDLYD | 621 | Q00610 | |
| IEHIGNLDRAYEFAE | 1086 | Q00610 | |
| IEHIGNLDRAYEFAE | 1086 | P53675 | |
| DLENLDEDGYTQLHF | 6 | Q9BXN2 | |
| VNEEHRGDFSYIGNL | 381 | Q9BPX3 | |
| AAEYDNFFQHLRLLD | 356 | Q7Z460 | |
| LFEYINQGDLHEFLI | 551 | Q01973 | |
| EDGDVQRHLYLQDVI | 51 | Q8NB15 | |
| SYEVARQAEELFHNL | 1901 | Q63HN8 | |
| HYRDDLDLQNLIDFG | 136 | Q86UF1 | |
| ALHLRGYVFQELRED | 371 | Q9NR97 | |
| LEEIFHQYSGEDRVL | 256 | Q8N3E9 | |
| DVELLQAFGDILHRY | 241 | Q9BSJ1 | |
| HYGQFLLEEARLIEA | 716 | Q8N394 | |
| LEHDVYERLTNLQEG | 961 | Q9H0E3 | |
| QRIHVDLFDLESGEY | 1181 | Q8IWV7 | |
| QQYLFDRLAHEIEAL | 1046 | O43847 | |
| EDNDLYDAITRGLHQ | 146 | A6NKC9 | |
| QAHLDELTRAYQFDI | 1166 | Q9HCK4 | |
| QGYRNFEDFLHESLV | 616 | Q9NW08 | |
| SDLYEDLRDGHNLIS | 201 | Q15149 | |
| LELHYQAFLRDSQDA | 1066 | Q15149 | |
| DLLHEDRLQYLQEEG | 71 | Q1RN00 | |
| LQGDEQRLYEFIVRH | 426 | Q13472 | |
| AELNYGLAHFVNEIR | 1116 | Q9UBW7 | |
| EIDLLLGQTDDTRYH | 156 | O75643 | |
| ERLYDLNHNEIGELI | 1151 | O75643 | |
| LHYQELQEGFSELEE | 171 | P0C7T8 | |
| FYVERNHVDLDSGLR | 166 | Q8WYQ9 | |
| LEDGYEQLRQLSQHA | 691 | Q7Z3V4 | |
| DGDFHTAIVLYNEAL | 71 | Q96AY4 | |
| YHEQQLGIAEDLKDR | 456 | Q96AY4 | |
| SIHELYGDEIQDFTQ | 1386 | O15050 | |
| LSEDVRYVIFGDDHL | 301 | A6NGJ6 | |
| GILLYNGDNDHIAVE | 1201 | O75093 | |
| LESYLQNHFVGLEDR | 336 | Q96IP4 | |
| DFQGLEHGDYREILE | 411 | Q6NT04 | |
| LSEDVRYVIFGDDHL | 301 | A6NI03 | |
| GDFYESEHGINIDLN | 1521 | P18583 | |
| NQEVLEILDFHLYGS | 511 | Q9H1B5 | |
| ANIDTIYDRFVHLDN | 1001 | Q14966 | |
| EAGYRLSDDQIVNHF | 51 | O95922 | |
| LILEHAGSYFDEIQQ | 1396 | O75962 | |
| LTDNGRHITYLEEEL | 146 | P49815 | |
| YEIQIEGDHEQGDLL | 211 | Q8NCN2 | |
| EYETAEQGLLNRHLL | 521 | P08048 | |
| EYDFRQQEGRFHEVL | 476 | A6NMK8 | |
| YQELQITAGRHGDDL | 361 | Q7Z794 | |
| TEEDQLLSYNDLRHF | 1456 | Q8IZF0 | |
| LHLGNLQYEARTFEN | 326 | Q13402 | |
| ILGYFLDQHDSEELD | 731 | Q5VTT5 | |
| LNEALERYGLNAEDF | 361 | Q6IQ20 | |
| HSEGYRQISALEDDL | 86 | Q9NXR1 |